News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Continue Reading Previous Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive OfficerNext EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 Related Stories News Appalachian Wireless Among First Regional Carriers to Launch RCS for Business with ClearSky News Saviynt Launches EU Identity Security Offering on French S3NS’s Trusted Cloud News Astra Security Connects Autonomous Pentesting to Claude Code and GitHub Copilot Through New MCP Server News G6 Hospitality’s North American Portfolio Grows to Over 1,600 Hotels News DTEX Introduces Precision Tuner for Continuous AI Security Optimization News Splashtop Joins Microsoft Virus Initiative, Strengthening Protection for Microsoft Environments